Cargando…
Myocardial proteomic profile in pulmonary arterial hypertension
Pulmonary arterial hypertension (PAH) is a rare, fatal, and incurable disorder. Although advances in the understanding of the PAH pathobiology have been seen in recent years, molecular processes underlying heart remodelling over the course of PAH are still insufficiently understood. Therefore, the a...
Autores principales: | Hołda, Mateusz K., Stachowicz, Aneta, Suski, Maciej, Wojtysiak, Dorota, Sowińska, Natalia, Arent, Zbigniew, Palka, Natalia, Podolec, Piotr, Kopeć, Grzegorz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7462861/ https://www.ncbi.nlm.nih.gov/pubmed/32873862 http://dx.doi.org/10.1038/s41598-020-71264-8 |
Ejemplares similares
-
Changes in heart morphometric parameters over the course of a monocrotaline-induced pulmonary arterial hypertension rat model
por: Hołda, Mateusz K., et al.
Publicado: (2020) -
Competency in ECG Interpretation Among Medical Students
por: Kopeć, Grzegorz, et al.
Publicado: (2015) -
ECG Markers of Hemodynamic Improvement in Patients with Pulmonary Hypertension
por: Waligóra, Marcin, et al.
Publicado: (2018) -
Corrigendum to “ECG Markers of Hemodynamic Improvement in Patients with Pulmonary Hypertension”
por: Waligóra, Marcin, et al.
Publicado: (2018) -
Triglyceride-to-High-Density Lipoprotein Cholesterol Ratio and Systemic Inflammation in Patients with Idiopathic Pulmonary Arterial Hypertension
por: Jonas, Kamil, et al.
Publicado: (2019)